Integration of Single-Cell RNA-Sequencing and Network Analysis to Investigate Mechanisms of Drug Resistance

Methods Mol Biol. 2023:2660:85-94. doi: 10.1007/978-1-0716-3163-8_7.

Abstract

Innate resistance and therapeutic-driven development of resistance to anticancer drugs is a common complication of cancer therapy. Understanding mechanisms of drug resistance can lead to development of alternative therapies. One strategy is to subject drug-sensitive and drug-resistant variants to single-cell RNA-seq (scRNA-seq) and to subject the scRNA-seq data to network analysis to identify pathways associated with drug resistance. This protocol describes a computational analysis pipeline to study drug resistance by subjecting scRNA-seq expression data to Passing Attributes between Networks for Data Assimilation (PANDA), an integrative network analysis tool that incorporates protein-protein interactions (PPI) and transcription factor (TF)-binding motifs.

Keywords: Connectivity map analysis; Data integration; Drug resistance network; Gene set enrichment analysis; Passing Attributes between Networks for Data Assimilation; Protein–protein interactions; Single-cell RNA-sequencing; Transcription factor-binding motifs.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Gene Expression Profiling* / methods
  • RNA*
  • Sequence Analysis, RNA / methods
  • Single-Cell Analysis / methods

Substances

  • RNA